School of Pharmacy, University of Auckland, Zealand.
Res Social Adm Pharm. 2011 Sep;7(3):294-305. doi: 10.1016/j.sapharm.2010.06.004. Epub 2010 Aug 5.
Generic medicines are commonly used in New Zealand; however, Pharmaceutical Management Agency of New Zealand (PHARMAC) has indicated a need for better information to the public. Studies on consumers' perceptions suggest that pharmacists play an important role in consumers' choice; hence, "quality use of generic medicines" can be promoted with a better understanding of pharmacists' views, knowledge, and perception.
(1)To evaluate pharmacists' perceptions, views, and knowledge of and willingness to recommend generic medicines. (2) To explore pharmacists perceptions of the safety, quality, and efficacy of generic medicines. (3) To assess pharmacists' views on current policy with respect to substitution of generic medicines.
A cross-sectional survey using a postal questionnaire was conducted, and questionnaires were sent to 625 randomly selected pharmacists from a list of 1594 pharmacists who had agreed to release their details for research purposes.
Three-hundred and sixty pharmacists responded to the questionnaire (a response rate of 58%). Seventy percent of pharmacists stated there is no difference in safety between original brand and generic medicines. However, 65% stated that original brand medicines were of higher quality than their generic counterparts, and half stated that generic medicines and original brand medicines are equally effective. A large number of pharmacists reported concerns regarding brand substitution and offered suggestions, such as the need for advertising campaigns, patient pamphlets, updating prescribers' software, and distinct packaging for generic medicines. It was found that pharmacists' perceptions of generic medicines are primarily driven by PHARMACs policies and their experiences with consumers.
About one-third of pharmacists correctly defined the term "generic medicines," suggesting discrepancies in pharmacists' knowledge and perceptions of generic medicines. Concerns were raised regarding: quality, safety, and effectiveness; however, most of the pharmacists acknowledged the economic benefits to the health care system.
新西兰常用仿制药,但新西兰药品管理局(PHARMAC)表示需要向公众提供更好的信息。消费者认知研究表明,药剂师在消费者选择中起着重要作用;因此,通过更好地了解药剂师的观点、知识和看法,可以促进“合理使用仿制药”。
(1)评估药剂师对仿制药的看法、认知、推荐意愿和知识。(2)探讨药剂师对仿制药安全性、质量和疗效的看法。(3)评估药剂师对仿制药替代现行政策的看法。
采用横断面调查,对 625 名随机抽取的药剂师进行了邮寄问卷调查,这些药剂师来自同意为研究目的提供其详细信息的 1594 名药剂师名单。
360 名药剂师对问卷做出了回应(回应率为 58%)。70%的药剂师表示,原研药和仿制药的安全性没有差异。然而,65%的药剂师表示原研药的质量优于仿制药,半数的药剂师表示仿制药和原研药的疗效相当。许多药剂师对品牌替代表示担忧,并提出了一些建议,如需要开展广告宣传活动、为患者提供宣传册、更新开处方软件,以及为仿制药采用不同的包装。研究发现,药剂师对仿制药的看法主要受 PHARMAC 政策和他们与消费者的经验驱动。
约有三分之一的药剂师正确定义了“仿制药”一词,这表明药剂师对仿制药的知识和认知存在差异。对质量、安全性和有效性表示了担忧;然而,大多数药剂师承认这对医疗保健系统具有经济效益。